CLINICAL_TRIALS
trial_result
· 2024-03-12
Clinical Trial Update: Study to Assess the Efficacy and Safety of Emapalumab in Primary Haemophagocytic Lymphohistiocytosis [Phase 3]
Summary
Phase 3 trial assessing efficacy and safety of emapalumab in primary hemophagocytic lymphohistiocytosis has completed with results posted in 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Swedish Orphan Biovitrum | Conditions: Primary Hemophagocytic Lymphohistiocytosis | Phase 3 | Status: COMPLETED | Results posted: 2024-03-12